Lemborexant + Bupropion Interaction
Moderateinteraction on record
Description
CYP2B6 substrate whose AUC is decreased by lemborexant, potentially reducing efficacy. Monitor for adequate clinical response and consider dose increase if needed.
Mechanism
CYP2B6 induction
Source: NLP:lemborexant